Christine Lihou

Christine Lihou is an accomplished clinical scientist with extensive experience in clinical development and research across various pharmaceutical companies. Currently serving as Executive Director, Clinical Scientist at Tyra Biosciences since February 2024, Lihou has held key leadership roles at Immuneering Corporation, Prelude Therapeutics, and Incyte, where responsibilities included overseeing clinical strategy, managing development plans for new product candidates, and leading clinical trials across oncology and supportive care therapies. With a Master's degree in Clinical Research Management from Arizona State University and a Graduate Certificate in Genetics and Genomics from Stanford University, Lihou combines robust academic qualifications with a comprehensive background in clinical operations and management, beginning with a BS in Biology from Moravian University.